J.-Y. Goujon et al. / Tetrahedron: Asymmetry 14 (2003) 1969–1972
1971
stituents such as sulfonyl, phosphoryl or carbonyl
groups.1 We were pleased to find that the correspond-
ing ring-opening products 14 could be obtained in good
yields and with a high degree of regioselectivity.12
Bicyclic iminosugar 13 was readily opened with thio-
phenol in the presence of triethylamine at room temper-
ature. In the presence of a catalytic amount of lithium
perchlorate, aziridine 13 underwent cleavage by pri-
mary or secondary amines under the mild conditions
recently developed by Yadav et al. for N-tosyl aziridine
(Table 1, entries 2–4).13 Aziridine 13 was opened by
MeOH in the presence of camphorsulfonic acid (0.1
equiv.) to give 14e in 40% yield (not optimized).
Regioselective ring opening also occurred with various
carboxylic acids in dichloromethane to provide the
corresponding 2-deoxy-a-homonojirimycin derivatives
14f-h in 74 to 82% yield (Table 1, entries 6–8).7,14 The
same experimental conditions using dibenzyl phosphate
afforded protected iminosugar phosphate 14i which was
debenzylated with 10% Pd/C in MeOH/HCl 4N (20/1)
to furnish the corresponding significant glycosyl phos-
phate mimetic 14j in 85% yield (Scheme 5). To our
knowledge, this is the first example of a ring-opening
reaction of an N-alkylated aziridine by a phosphate.15
Compound 14j is a potential inhibitor of enzymes pro-
cessing Glc-1-P and could be the precursor of novel
UDP-Glc analogs as glycosyltransferase inhibitors.2c,d
reaction led to an untractable mixture of products
(using Na/NH3) or to the cleavage of the aziridine ring
to give the a-1-C-methyl analogue of 15 in quantitative
yield (using H2, Pd/C). To overcome this difficulty, we
first cleaved the benzyl groups at the stage of the
a-1-C-iodomethyl derivative 12a to generate 16. The
expected bicyclic iminosugar 17 was then obtained by
intramolecular nucleophilic substitution promoted by
K2CO3 in water (Scheme 7).18
Scheme 7. Reagents and conditions: (a) TMSI (8.5 equiv.),
CH2Cl2, 0°C to rt, 16 h, 84%; (b) K2CO3 (1.8 equiv.), H2O, 4
h, 90%.
In conclusion, ring-opening reactions of aziridine 13
with various heteroatomic nucleophiles provided a gen-
eral approach to fagomine a-C-glycosides and related
compounds. The nine-step reaction sequence proceeded
in an overall yield of 14–28% from tri-O-benzyl-D-glu-
cal 7. In the course of this study, the first synthesis of
a-1-C-ethyl-fagomine 16 has been achieved as well as
that of 1,N-anhydro derivatives of fagomine. Investiga-
tions on the activity of the synthesized fagomine C-gly-
cosides, especially as glycosidase and glycogen
phosphorylase inhibitors, are in progress and will be
reported in due course.
Scheme 5. Reagents and conditions: (a) (BnO)2P(O)OH (1.3
equiv.), CH2Cl2, 16 h, 78%; (b) H2, Pd/C, MeOH/HCl 4N
cat., 24 h, 85%.
Acknowledgements
We then turned our attention to organometallic nucleo-
philes in order to synthesize inter alia a-1-C-ethyl-
fagomine 3, the only example of a fagomine C-gly-
coside recently isolated from Adenophora triphylla var.
japonica.5 The reaction of aziridine 13 with various
organometallic reagents (MeLi, Me2CuLi, MeCeCl2)
failed to give the desired product 15 under various
experimental conditions. However, 15 could be
obtained in 65% yield after purification by flash chro-
matography by the reaction of Me2CuLi with the mix-
ture of the two stereoisomers 12 (Scheme 6).16
The authors express their gratitude to Yann Bilbille for
assistance with synthetic work and to Kyoko Ikeda for
optical activity and spectral data measurements. Finan-
cial support of this study by grants from CNRS and the
association ‘Vaincre les Maladies Lysosomales’ is also
gratefully acknowledged.
References
1. For recent reviews, see: (a) Sweeney, J. B. Chem. Soc.
Rev. 2002, 31, 247; (b) McCoull, W.; Davis, F. A. Syn-
thesis 2000, 1347.
2. (a) Stu¨tz, A. E. Iminosugars as Glycosidase Inhibitors:
Nojirimycin and Beyond; Wiley-VCH: Weinheim, 1999;
(b) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W.
J. Tetrahedron: Asymmetry 2000, 11, 1645; (c) Compain,
P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077; (d)
Compain, P.; Martin, O. R. Curr. Top. Med. Chem. 2003,
3, 541; (e) Schramm, V. L.; Tyler, P. C. Curr. Top. Med.
Chem. 2003, 3, 525; (f) Lee, R. E.; Smith, M. D.; Picker-
ing, L.; Fleet, G. W. J. Tetrahedron Lett. 1999, 39, 8689.
3. Iminosugars: Recent Insights Into Their Bioactivity and
Potential As Therapeutic Agents in Curr. Top. Med.
Chem.; Martin, O. R.; Compain, P., Eds.; Bentham,
Neth., 2003, 3, issue 5.
Scheme 6. Reagents and conditions: (a) Me2CuLi (1.1 equiv.),
THF, −50°C to rt, 6 h, 65%; (b) H2, Pd/C, EtOH, HCl 4N
cat., 24 h, 88%.
Removal of the benzyl protecting groups in 15 provided
the expected a-1-C-ethyl fagomine 3 in 88% yield.17
Finally, we investigated the deprotection of aziridine 13
in order to obtain the 1,N-anhydro derivative of
fagomine 17. Under usual debenzylation conditions, the